International Journal of Gynecological Cancer
Journal Abbreviation: INT J GYNECOL CANCER
ISSN: 1048-891X
Publisher: Lippincott, Williams & Wilkins / Wiley-Blackwell: No OnlineOpen
Publications (6)
Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial (2023)
Lorusso D, Mouret-Reynier MA, Harter P, Cropet C, Caballero C, Wolfrum-Ristau P, Satoh T, et al.
Journal article
Association between obesity and vulvar cancer recurrence: An analysis of the AGO-CaRE-1 study (2020)
Klapdor R, Hillemanns P, Woelber L, Jueckstock J, Hilpert F, De Gregorio N, Hasenburg A, et al.
Journal article
P53 AND P16 EXPRESSION PROFILES IDENTIFY THREE PROGNOSTICALLY SUBGROUPS IN VULVAR CANCER: A TMA BASED STUDY BY THE AGO-CARE-TRANSLATIONAL STUDY GROUP (2019)
Woelber L, Prieske K, Eulenburg C, De Gregorio N, Klapdor R, Kalder M, Braicu I, et al.
Conference contribution
VILLOGLANDULAR ADENOCARCINOMA OF THE UTERINE CERVIX: SUPPORT FOR LESS INVASIVE MANAGEMENT (2019)
Dietl A, Aumann K
Conference contribution
OLAPARIB IN GERMAN ROUTINE CLINICAL PRACTICE - INTERIM RESULTS OF THE NON-INTERVENTIONAL STUDY C-PATROL (2017)
Marme F, Sehouli J, Welslau M, Schinkoethe T, El-Balat A, Fasching P, Glowik R, Hilpert F
Conference contribution
Efficacy and safety of AEZS-108 (LHRH agonist linked to doxorubicin) in women with advanced or recurrent endometrial cancer expressing LHRH receptors: a multicenter phase 2 trial (AGO-GYN5) (2014)
Emons G, Gorchev G, Harter P, Wimberger P, Staehle A, Hanker L, Hilpert F, et al.
Journal article
